Mpox has returned to the global health conversation as authorities strengthen surveillance and refine response strategies to prevent renewed outbreaks. While case numbers remain contained in most regions, health agencies are emphasizing early detection, targeted vaccination, and public awareness to avoid a repeat of earlier disruptions. The disease’s transmission patterns, clinical presentation, and containment costs have prompted policymakers to treat mpox as a standing public health risk rather than a one-off event.